HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
<p>Aspects of comorbidity in patients with chronic heart failure are discussed. A focus on hyperuricemia, its effect on the course and prognosis in patients with heart failure, as well as the possibility of its medical correction are maintained.</p>
Main Authors: | M. V. Ledyakhova, S. N. Nasonova, S. N. Tereshchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/134 |
Similar Items
-
Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01) -
CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01) -
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01) -
Hyperuricemia: contemporary treatment in patients with cardiovascular disease
by: O. Yu. Mironova
Published: (2022-05-01) -
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)